To determine translational significance of these changes and prove EPCs as juvenile protective factors, we tested whether infusing juvenile cd45- [cd34+/kdr+]EPCs can delay stroke onset in spTg25+ female rats, known to be the more susceptible to ischemic-hemorrhagic strokes than male rats [7]. This evidence concerns the gene CD34 and Stroke.